Cannabis use was linked to 6 times higher odds of medication overuse headache in chronic migraine patients

Among 368 chronic migraine patients, cannabis users had 6.3 times higher adjusted odds of medication overuse headache compared to non-users, with cannabis use also correlated with opioid use.

Zhang, Niushen et al.·Headache·2021·Moderate EvidenceCase-Control
RTHC-03634Case ControlModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case-Control
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Medication overuse headache was present in 81% of cannabis-using chronic migraine patients vs. 41% of non-users (adjusted OR 6.3, 95% CI 3.56-11.1). Cannabis use was significantly correlated with opioid use (rho=0.26), and cluster analysis revealed a high-risk group with 9.3 times more cannabis use and 9.2 times more opioid use.

Key Numbers

Patients: 368 (212 MOH, 156 no MOH). Cannabis users with MOH: 81% vs. 41%. Adjusted OR: 6.3 (95% CI 3.56-11.1). Cannabis-opioid correlation: rho=0.26. Cluster I: 9.3x more cannabis, 9.2x more opioids, 1.8x more MOH.

How They Did This

Case-referent study of 368 chronic migraine patients from headache clinics (2015-2019). Compared 212 with medication overuse headache to 156 without. Used logistic regression and agglomerative hierarchical clustering.

Why This Research Matters

Many migraine patients use cannabis expecting symptom relief, but this study suggests it may actually worsen the cycle of medication overuse that perpetuates chronic headache.

The Bigger Picture

The strong cannabis-opioid-MOH cluster suggests these substances may share underlying mechanisms in medication overuse headache, challenging the assumption that cannabis is a safer alternative for migraine management.

What This Study Doesn't Tell Us

Cross-sectional design cannot determine whether cannabis causes MOH or whether MOH patients seek cannabis for relief. Single-center study. No data on cannabis type, dose, or frequency.

Questions This Raises

  • ?Does cannabis perpetuate the rebound headache cycle similarly to other acute treatments?
  • ?Would cannabis cessation improve MOH in this population?

Trust & Context

Key Stat:
81% of cannabis-using migraine patients had medication overuse headache vs. 41% of non-users
Evidence Grade:
Well-designed case-referent study with appropriate statistical methods, but cross-sectional design limits causal inference.
Study Age:
Published in 2021 with data from 2015-2019.
Original Title:
Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.
Published In:
Headache, 61(8), 1234-1244 (2021)
Database ID:
RTHC-03634

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Compares people with a condition to similar people without it.

What do these levels mean? →

Frequently Asked Questions

Can cannabis cause medication overuse headache in migraine patients?

This study found cannabis users with chronic migraine had 6.3 times higher odds of medication overuse headache, though the direction of causation is unclear.

Is there a link between cannabis and opioid use in migraine patients?

Yes. Cannabis use was significantly correlated with opioid use, and a cluster analysis identified a high-risk group using both substances at much higher rates.

Read More on RethinkTHC

Cite This Study

RTHC-03634·https://rethinkthc.com/research/RTHC-03634

APA

Zhang, Niushen; Woldeamanuel, Yohannes W. (2021). Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.. Headache, 61(8), 1234-1244. https://doi.org/10.1111/head.14195

MLA

Zhang, Niushen, et al. "Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.." Headache, 2021. https://doi.org/10.1111/head.14195

RethinkTHC

RethinkTHC Research Database. "Medication overuse headache in patients with chronic migrain..." RTHC-03634. Retrieved from https://rethinkthc.com/research/zhang-2021-medication-overuse-headache-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.